ACTA1 and infection: Immunohistochemical analysis revealed significant reductions in the areas of Col1(α1), Col3(α1), and α-SMA on days 42 and 56 post-infection in the rAAV8-anti-miR-30-treated group compared to that in both the NC and PBS groups (Figures 4D, E).